The role and significance of Down syndrome screening

Down syndrome screening is a prenatal screening method that uses blood tests and ultrasounds to assess the risk of a fetus having chromosomal abnormalities such as Down syndrome. Its core functions includerisk assessment(such as trisomy 21, trisomy 18),Decision aid(Whether further diagnosis is needed) andearly intervention(Recommendations for follow-up examinations for high-risk pregnant women). The main content is divided into three parts: screening principle (combining maternal serum markers and fetal NT value), applicable population (all pregnant women, especially those with advanced age or family history), and result interpretation (risk value classification and clinical significance).

Screening principles and testing items

Down syndrome screening analyzes the blood of pregnant womenHCG, AFP and other hormone levels, combined with ultrasonic measurementFetal nuchal translucency (NT) thickness, comprehensively calculate the risk value. For example, the "combined screening" in the first trimester (11-13 weeks) includes NT examination and serum marker testing, while the second trimester (15-20 weeks) focuses on serological "triple screening". Although this non-invasive method cannot confirm the diagnosis, it can effectively screen high-risk groups and provide a basis for subsequent diagnostic examinations such as amniocentesis.

Applicable groups and screening timing

In theory, all pregnant women should be screened for Down syndrome, butPregnant women over 35 years old,Have a family history of chromosomal abnormalitiesorpast adverse pregnancy historyneed to pay more attention. The screening time window is strict: first trimester screening needs to be completed between 11 and 13 weeks, and second trimester screening between 15 and 20 weeks. Missing the opportunity may result in inaccurate results. It should be noted that the screening results are affected by factors such as the maternal age and weight, and need to be comprehensively evaluated by a doctor.

Interpretation of results and follow-up measures

Screening results are usuallyrisk ratio(such as 1/1000), the critical value is generally 1/270. A value higher than this is considered a high risk and needs to be further confirmed through amniocentesis or NIPT (non-invasive DNA); a low risk does not rule out the possibility of abnormality and needs to be combined with other tests. Doctors will provide personalized recommendations based on the results to avoid unnecessary anxiety caused by false positives. It is worth noting that the detection rate of Down syndrome screening is about 60%-90%, which has certain limitations.

Summary and scientific understanding

Down syndrome screening is an important part of prenatal care and can effectively reduce the birth rate of fetuses with chromosomal abnormalities, but it needs to be clarified.Screening rather than diagnosisnature. Pregnant women should view the results rationally and cooperate with their doctors in formulating follow-up plans. With the advancement of technology, new tests such as NIPT can make up for the shortcomings of traditional screening, but the cost is higher. It is recommended that pregnant women choose the appropriate plan according to their own situation and under professional guidance.

Quote sources:

1. "Guidelines for Preconception and Pregnancy Health Care (2022)" by the Obstetrics and Gynecology Branch of the Chinese Medical Association 2. American College of Obstetricians and Gynecologists (ACOG) Practice Bulletin No. 226 3. Relevant testing technology providers: BGI (NIPT), Berry and Kang (non-invasive DNA testing)